UNSPSC 85751904: Revision of infusion device in penis, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in penis, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VWS43Z

UNSPSC 85751904 Revision of infusion device in penis, percutaneous endoscopic approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's nominal scope describes a specific urological surgical procedure, yet the six recent state and local opportunities tagged under it involve occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for disability determinations, specialty surgical networks, and emergency medical services for detained youth—none of which involve infusion device revision or percutaneous endoscopic procedures. The mismatch suggests either incorrect code assignment in the source data or a fundamental disconnect between the code's intended scope and actual procurement tagging practice at issuing bodies.

Activity spans multiple states and issuing-body types: the Washington State Department of Transportation posted an occupational medical surveillance RFP due October 9, 2026; the City of Phoenix Retirement Office posted an independent medical evaluation services RFP due October 16, 2026 with a maximum contract value of $750,000 over five years; the City of Long Beach posted a surgical and medical procedure carve-out RFP due October 7, 2026; the County of Santa Clara Health System posted a temporary health professional staffing services RFP due October 7, 2026; Harris County Juvenile Probation Department posted an RFI for specialty medical services due September 25, 2026; and Collier County Board of County Commissioners posted a pharmacy benefit management services RFP with a historical spend baseline of approximately $8.7 million annually. Geographic presence includes Washington, Arizona, California, Texas, and Florida. Given the code's name and the actual work being solicited, this code appears unsuitable for business development targeting under its stated scope.